MeSH tree: C15.378.553
A groundbreaking study led by National Jewish Health researchers suggests that the skin may serve as a potential biomarker for a chronic allergic disease of the esophagus called eosinophilic esophagitis (EoE) in children. ...
Jun 7, 2025
0
21
A new study from Cedars-Sinai has examined whether a specialized diet could improve symptoms of gastrointestinal disorders linked to an imbalance in gut microbiota.
Apr 1, 2025
0
53
A new study published in JCI Insight suggests that interleukin-7 (IL-7), a key immune-boosting cytokine, may help critically ill COVID-19 patients by reducing life-threatening secondary infections. Led by Richard S. Hotchkiss, ...
Apr 1, 2025
0
22
The U.S. Food and Drug Administration has removed one hurdle faced by patients with schizophrenia when filling prescriptions for the antipsychotic medication clozapine.
Mar 3, 2025
0
21
A multi-institutional study led by researchers at Children's Hospital of Philadelphia (CHOP) is the first to identify one of the allergens responsible for eosinophilic esophagitis (EoE), an inflammatory disease of the esophagus. ...
Feb 3, 2025
0
29
For a child battling cancer, an unexpectedly high temperature can initiate a race against time to reach providers who can treat and monitor symptoms. And for families in low- and middle-income communities in Mexico, pediatric ...
Jan 28, 2025
0
17
In a clinical guideline issued by the American College of Gastroenterology and published in the January issue of the American Journal of Gastroenterology, recommendations are presented for the diagnosis and management of ...
Jan 24, 2025
0
43
An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate (MTX), according to a new study by investigators at Mass General Brigham.
Jan 6, 2025
0
15
A thesis from Karolinska Institutet shows the significant societal economic burdens posed by two chronic inflammatory gastrointestinal diseases; eosinophilic esophagitis (EoE) and microscopic colitis (MC). Both diseases cause ...
Dec 3, 2024
0
13
A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality. On average, it took eight days to recover for patients ...
Nov 14, 2024
0
31
